Navigation Links
FDA, NIH and Genzyme Reveal Their Strategies to Overcome Viral Contamination at the Pathogen Safety Summit
Date:9/5/2012

LONDON, September 6, 2012 /PRNewswire/ --

Leading biotech and biopharma organisations are coming together to learn how to maximise their viral security strategies and the new technologies available from the FDA, NIBSC, NIH and a range of industry experts including Genzyme, Baxter and Amgen  at the Pathogen Safety Summit this November.

Pharma IQ's Pathogen Safety Summit is back for its third year to offer the opportunity to learn and hear insights from key regulatory bodies, industry representatives and experts in viral safety on the current viral security strategies and technologies.

As the cost of contamination is huge, both financially and to an organisation's reputation, this event will cover:

  • The latest regulatory updates on viral safety from Arifa Khan, FDA and Dr Wahiba Oualikene-Gonin, AFSAAPS
  • James Gilbert, Biogen Idec and  Lada Laenen, Genzyme,  will share  best practices for the successful evaluation of raw materials
  • Knowledge of the most prevalent pathogens currently being found in biologics from Phil Minor, NIBSC
  • Adam Polermo, Genzyme, present the latest data on the implementation of deep sequencing technologies
  • Rebecca Sheets, NIH, streamlines the viral screening process and rationalise the implementation of the latest technologies

This interactive, senior-level summit will allow organisations to benchmark themselves against the leading experts in biosafety.

Find the full program, event details and registration information at http://www.pathogensafetysummit.com/news, call +44(0)20-7036-1300 or email enquire@iqpc.co.uk.  

Media contact: Nishkala Thiru, +44(0)20-7368-9725, Nishkala.Thiru@iqpc.co.uk or visit http://www.pathogensafetysummit.com/news.

Press are invited to attend this important industry forum, if you would like a complimentary press pass please email Nishkala Thiru at Nishkala.Thiru@iqpc.co.uk    



'/>"/>
SOURCE Pharma IQ
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Magnetic vortex reveals key to spintronic speed limit
2. The Insider Secrets of Back Pain Treatment Revealed
3. Martha Stewart Reveals the Secret Behind her Radiant Skin is Revolutionary Anti-aging BIOEFFECT EGF SERUM
4. Researchers reveal why some pain drugs become less effective over time
5. ORNL microscopy reveals atomic antenna behavior in graphene
6. Carnegie Mellon study reveals potential of manganese in neutralizing deadly Shiga toxin
7. Graphene reveals its magnetic personality
8. Survey Reveals Paternity Questions Loom for More Than One in 10 Americans
9. Imprisoned molecules quantum rattle in their cages
10. Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Prepare for FDA Inspections of Their Quality Systems
11. Oncobiologics, Inc. Announces a Collaboration Agreement with XOMA Corporation to Utilize XOMAs Fully Human Antibody Libraries for Their Discovery Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... CLEVELAND , June 27, 2016  Global ... average 4.6 percent through 2020 to $7.2 billion.  ... (food and beverages, cleaning products, biofuel production, animal ... and biotechnology, diagnostics, and biocatalysts). Food and beverages ... gains driven by increasing consumption of products containing ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... to bring innovative medical technologies, services and solutions to the healthcare market. The ... implementation of various distribution, manufacturing, sales and marketing strategies that are necessary to ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016  The American College of ... Trade Show Executive Magazine as one of the fastest-growing ... May 25-27 at the Bellagio in Las Vegas ... the highest percentage of growth in each of the following ... exhibiting companies and number of attendees. The 2015 ACMG Annual ...
(Date:6/20/2016)... 20, 2016 Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring announced ... it has secured the final acceptance by all ... Managed Access Systems (MAS) installed. Furthermore, Securus will ... be installed by October, 2016. MAS distinguishes between ...
(Date:6/9/2016)... Paris Police Prefecture ... solution to ensure the safety of people and operations in ... major tournament Teleste, an international technology group specialised ... today that its video security solution will be utilised by ... public safety across the country. The system roll-out is scheduled ...
Breaking Biology News(10 mins):